Cogent Biosciences

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. They make money by advancing their pipeline of targeted treatments through clinical trials and partnering with other pharmaceutical companies for development and commercialization. Founded in 2014 and formerly known as Unum Therapeutics, the company rebranded in 2020 to better reflect its strategic focus on precision medicine. Their lead program, bezuclastinib, targets specific mutations in cancer, showcasing their commitment to innovative, targeted therapies.

Recent Posts by Cogent Biosciences

1-20 of 193